Viewing Study NCT05221658


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-01-04 @ 12:12 PM
Study NCT ID: NCT05221658
Status: UNKNOWN
Last Update Posted: 2022-08-29
First Post: 2022-01-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module